Investigation on a Topical Cosmetic Pain Lotion (Egyfil) for Stiffness and Pain Relief

The application of a novel topical formulation for the treatment of muscular pain and stiffness (Egyfil), containing hyaluronic acid, SH-Polypeptide-6 and SH-Oligopeptide-1, is investigated to evaluate efficacy and safety in 26 patients with stiffness and pain. Single-Arm, Pre-Market, interventional study.

Eligibility Criteria

Inclusion Criteria:signed participants informed consent form (ICF);male or Female, aged 18 - 60 years at the time of the signature of ICF;3 to 10 rating according to the Numerical Rating Scale (NRS), applied in participants with muscle tension pain;willing to follow all study procedures;willing to follow indications.Exclusion Criteria:use of analgesics within the 24 hours prior to V1;damaged skin in the area of treatment;infective or prior inflammatory processes near the area of treatment;ongoing cutaneous allergies;serious and chronical pathological skin conditions (i.e., rosacea, psoriasis, vitiligo) including diagnosticated cancer with/without ongoing antitumor therapy;allergy to lotion components (aqua (water), glycerin, caprylic/capric triglyceride, aloe barbadensis leaf juice powder, simmondsia chinensis seed oil (simmondsia chinensis (jojoba) seed oil), phenoxyethanol, ammonium acryloyldimethyltaurate/vp copolymer, carbomer, tocopheryl acetate, tocopherol, benzoic acid, sodium hydroxide, sodium hyaluronate, dehydroacetic acid, ethylhexylglycerin, butyrospermum parkii butter (butyrospermum parkii (shea butter)), sorbitol, SH-polypeptide 6; SH-oligopeptide-1immune system illnesses;uncontrolled systemic diseases;known drug and/or alcohol abuse;mental incapacity that precludes adequate understanding or cooperation;participation in another investigational study.

Source: ClinicalTrials.gov (NCT05711953). StuddyBuddy aggregates publicly available trial information.

Investigation on a Topical Cosmetic Pain Lotion (Egyfil) for Stiffness and Pain Relief

Summary

Eligibility Criteria